Friday, May 20, 2016

Note: This is a public post and this is for information

HIV Overview

HIV/AIDS: The Basics

(Last updated 9/15/2015; last reviewed 9/15/2015)


Key Points


·  HIV is the virus that causes HIV infection. AIDS is the most advanced stage of HIV infection.
·  HIV is spread through contact with the blood, semen, pre-seminal fluid, rectal fluids, vaginal fluids, or breast milk of a person infected with HIV. In the United States, HIV is spread mainly by having anal or vaginal sex or sharing drug injection equipment with a person infected with HIV.
·  The use of HIV medicines to treat HIV infection is called antiretroviral therapy (ART). ART involves taking a combination of HIV medicines (called an HIV regimen) every day. 
·  ART can’t cure HIV infection, but it can help people infected with HIV live longer, healthier lives. HIV medicines can also reduce the risk of transmission of HIV.

What is HIV/AIDS?

HIV stands for human immunodeficiency virus, which is the virus that causes HIV infection. The abbreviation “HIV” can refer to the virus or to HIV infection. 

AIDS stands for acquired immunodeficiency syndrome. AIDS is the most advanced stage of HIV infection.

HIV attacks and destroys the infection-fighting CD4 cells of the immune system. Loss of CD4 cells makes it difficult for the body to fight infections and certain cancers. Without treatment, HIV can gradually destroy the immune system and advance to AIDS.

How is HIV spread?

HIV is spread through contact with certain body fluids from a person infected with HIV. These body fluids include:
  • Blood
  • Semen
  • Pre-seminal fluid
  • Vaginal fluids
  • Rectal fluids
  • Breast milk
The spread of HIV from person to person is called HIV transmission. The spread of HIV from an HIV-infected woman to her child during pregnancy, childbirth, or breastfeeding is called mother-to-child transmission of HIV.
 
In the United States, HIV is spread mainly by having sex with or sharing drug injection equipment with someone who is infected with HIV. To reduce your risk of HIV infection, use condoms correctly and consistently during sex, limit your number of sexual partners, and never share drug injection equipment. 

Mother-to-child transmission is the most common way that children become infected with HIV. HIV medicines, given to HIV-infected women during pregnancy and childbirth and to their babies after birth, reduce the risk of mother-to-child transmission of HIV.  

You can’t get HIV by shaking hands or hugging a person infected with HIV. You also can’t get HIV from contact with objects such as dishes, toilet seats, or doorknobs used by a person with HIV.


What is the treatment for HIV?

The use of HIV medicines to treat HIV infection is called antiretroviral therapy (ART). ART involves taking a combination of HIV medicines (called an HIV regimen) every day. (HIV medicines are often called antiretrovirals or ARVs.) 

ART prevents HIV from multiplying and reduces the level of HIV in the body. Having less HIV in the body protects the immune system and prevents HIV infection from advancing to AIDS. 

ART can’t cure HIV, but it can help people infected with HIV live longer, healthier lives. ART also reduces the risk of HIV transmission.

What are the symptoms of HIV/AIDS?

Soon after infection with HIV, some people have flu-like symptoms, such as fever, headache, or rash. The symptoms may come and go for a month or two after infection. 

After this earliest stage of HIV infection, HIV continues to multiply but at very low levels. More severe symptoms of HIV infection, such as chronic diarrhea, rapid weight loss, and other signs of opportunistic infections, generally don’t appear for many years. (Opportunistic infections are infections and infection-related cancers that occur more frequently or are more severe in people with weakened immune systems than in people with healthy immune systems.)

Without treatment, HIV can advance to AIDS. The time it takes for HIV to advance to AIDS varies, but it can take 10 years or more.

HIV transmission is possible at any stage of HIV infection—even if an HIV-infected person has no symptoms of HIV.

How is AIDS diagnosed?

The following criteria are used to determine if a person infected with HIV has AIDS:
  • The person’s immune system is severely damaged as indicated by a CD4 count of less than 200 cells/mm3. A CD4 count measures the number of CD4 cells in a sample of blood. The CD4 count of a healthy person ranges from 500 to 1,600 cells/mm3.
    AND/OR
  • The person has one or more opportunistic infections.

How can I learn more about HIV/AIDS?

  • Read quick facts about HIV transmission.
  • Read this webpage: How Do You Get HIV or AIDS?

This fact sheet is based on information from the following sources:

  • From the Centers for Disease Control and Prevention (CDC): 
    HIV Basics 
  • From the National Institute of Allergy and Infectious Diseases (NIAID): 
    Understanding HIV/AIDS 
AIDSinfo logo

HIV Overview

The HIV Life Cycle

(Last updated 9/22/2015; last reviewed 9/22/2015)

Key Points

·  HIV uses the machinery of the CD4 cells to multiply (make copies of itself) and spread throughout the body. This process, which includes seven steps or stages, is called the HIV life cycle. HIV medicines protect the immune system by blocking HIV at different stages of the HIV life cycle.·  HIV gradually destroys the immune system by attacking and killing CD4 cells. CD4 cells are a type of white blood cell that play a major role in protecting the body from infection.
·  Antiretroviral therapy or ART is the use of HIV medicines to treat HIV infection. People on ART take a combination of HIV medicines from at least two different HIV drug classes every day. Because HIV medicines in different drug classes block HIV at different stages of the HIV life cycle, ART is very effective at preventing HIV from multiplying. ART also reduces the risk of HIV drug resistance.
·  ART can’t cure HIV, but HIV medicines help people with HIV live longer, healthier lives. ART also reduces the risk of sexual transmission of HIV.
Once a person is infected with HIV, the virus begins to attack and destroy the CD4 cells of the immune system. CD4 cells are a type of white blood cell that play a major role in protecting the body from infection. HIV uses the machinery of the CD4 cells to multiply (make copies of itself) and spread throughout the body. This process, which includes seven steps or stages, is called the HIV life cycle.

What is the connection between the HIV life cycle and HIV medicines?

Antiretroviral therapy (ART) is the use of HIV medicines to treat HIV infection. HIV medicines protect the immune system by blocking HIV at different stages of the HIV life cycle.
HIV medicines are grouped into different drug classes according to how they fight HIV. Each class of drugs attacks HIV at a different stage of the HIV life cycle. 

People on ART take a combination of HIV medicines from at least two different HIV drug classes every day. Because HIV medicines in different drug classes block HIV at different stages of the HIV life cycle, ART is very effective at preventing HIV from multiplying. Having less HIV in the body protects the immune system and prevents HIV from advancing to AIDS. ART also reduces the risk of HIV drug resistance.
ART can’t cure HIV, but HIV medicines help people with HIV live longer, healthier lives. HIV medicines also reduce the risk of sexual transmission of HIV.

What are the seven stages of the HIV life cycle?

The seven stages of the HIV life cycle are: 1) binding, 2) fusion, 3) reverse transcription, 4) integration, 5) replication, 6)assembly, and 7) budding. To understand each stage in the HIV life cycle, it helps to first imagine what HIV looks like.


Now follow each stage in the HIV life cycle, as HIV attacks a CD4 cell and uses the machinery of the cell to multiply.
HIV Life Cycle Image

How can I learn more about the HIV life cycle?

Read information from the National Institute of Allergy and Infectious Diseases (NIAID) on how HIV causes AIDS. This fact sheet is based on this information. 

AIDSinfo logo

HIV Overview

The Stages of HIV Infection

(Last updated 9/15/2015; last reviewed 9/15/2015)

Key Points

·  Without treatment, HIV infection advances in stages, getting worse over time.
·  The three stages of HIV infection are (1) acute HIV infection, (2) chronic HIV infection, and (3) acquired immunodeficiency syndrome (AIDS).
·  HIV can be transmitted (spread to others) during any stage of infection, but the risk is greatest during acute HIV infection.
·  There is no cure for HIV infection, but HIV medicines (called antiretroviral medicines) can prevent HIV from advancing to AIDS. HIV medicines help people with HIV live longer, healthier lives. HIV medicines also reduce the risk of HIV transmission (the spread of HIV to others).
Without treatment, HIV infection advances in stages, getting worse over time. HIV gradually destroys the immune system and eventually causes acquired immunodeficiency syndrome (AIDS). 

There is no cure for HIV infection, but HIV medicines (called antiretroviral medicines) can prevent HIV from advancing to AIDS. HIV medicines help people with HIV live longer, healthier lives. HIV medicines also reduce the risk of HIV transmission (the spread of HIV to others). 
https://aidsinfo.nih.gov/images/factsheet/HIVProgression800.jpg

There are three stages of HIV infection:
1.    Acute HIV Infection
Acute HIV infection is the earliest stage of HIV. Acute HIV infection generally develops within 2 to 4 weeks after a person is infected with HIV. During acute HIV infection, many people have flu-like symptoms, such as fever, headache, and rash. In this acute stage of infection, HIV multiplies rapidly and spreads throughout the body. The virus attacks and destroys the infection-fighting CD4 cells of the immune system. HIV can be transmitted during any stage of infection, but the risk is greatest during acute HIV infection.


2.    Chronic HIV Infection
The second stage of HIV infection is chronic HIV infection (also called asymptomatic HIV infection or clinical latency). During this stage of the disease, HIV continues to multiply in the body but at very low levels. People with chronic HIV infection may not have any HIV-related symptoms, but they can still spread HIV to others. Without treatment with HIV medicines, chronic HIV infection usually advances to AIDS in 10 to 12 years.


3.    AIDS 
AIDS is the final stage of HIV infection. Because HIV has destroyed the immune system, the body can’t fight offopportunistic infections and cancer. (Examples of opportunistic infections include pneumonia and tuberculosis.) AIDS is diagnosed when a person with HIV has a CD4 count of less than 200 cells/mm
3 and/or one or more opportunistic infections. Without treatment, people with AIDS typically survive about 3 years.

This fact sheet is based on information from the following sources:

  • From AIDS.gov: Stages of HIV Infection 
  • From the Centers for Disease Control and Prevention (CDC): HIV/AIDS Basics 
  • From the National Institute of Allergy and Infectious Diseases (NIAID): More on How HIV Causes AIDS
AIDSinfo logo

HIV Overview

HIV Testing

(Last updated 9/24/2015; last reviewed 9/24/2015)

Key Points

·  HIV testing shows whether a person is infected with HIV. HIV stands for human immunodeficiency virus. HIV is the virus that causes AIDS (acquired immunodeficiency syndrome). AIDS is the most advanced stage of HIV infection.
·  The Centers for Disease Control and Prevention (CDC) recommends that everyone 13 to 64 years old get tested for HIV at least once and that people at high risk of infection get tested more often.
·  Risk factors for HIV infection include having unprotected sex (sex without a condom); having sex with many partners; and injecting drugs and sharing needles, syringes, or other drug equipment with others.
·  CDC recommends that all pregnant women get tested for HIV as early as possible during each pregnancy.

What is HIV testing?

HIV testing shows whether a person is infected with HIV. HIV stands for human immunodeficiency virus. HIV is the virus that causes AIDS (acquired immunodeficiency syndrome). AIDS is the most advanced stage of HIV infection.

HIV testing can detect HIV infection, but it can’t tell how long a person has been HIV infected or if the person has AIDS.

Why is HIV testing important?

Knowing your HIV status can help keep you—and others—safe.

If you are HIV negative:
Testing shows that you don’t have HIV. Continue taking steps to avoid getting HIV, such as using condoms during sex. For more information, read the AIDSinfo fact sheet on HIV prevention. 

If you are HIV positive:
Testing shows that you are infected with HIV, but you can still take steps to protect your health. Begin by talking to your health care provider about antiretroviral therapy (ART). ART is the use of HIV medicines to treat HIV infection. People on ART take a combination of HIV medicines every day. ART helps people with HIV live longer, healthier lives. ART also reduces the risk of sexual transmission of HIV. Your health care provider will help you decide when to start ART and what HIV medicines to take.

Who should get tested for HIV?

The Centers for Disease Control and Prevention (CDC) recommends that everyone 13 to 64 years old get tested for HIV at least once and that people at high risk of infection get tested more often. 

Factors that increase the risk of HIV infection include:
  • Having vaginal or anal sex without using a condom with someone who is HIV positive or whose HIV status you don’t know
  • Injecting drugs and sharing needles, syringes, or other drug equipment with others
  • Exchanging sex for money or drugs
  • Having a sexually transmitted disease (STD), such as syphilis
  • Having hepatitis or tuberculosis (TB)   
  • Having sex with anyone who has any of the HIV risk factors listed above
Talk to your health care provider about your risk of HIV infection and how often you should get tested for HIV.

Should pregnant women get tested for HIV?

CDC recommends that all pregnant women get tested for HIV as early as possible during each pregnancy. Women who are planning to get pregnant should also get tested.
Women with HIV take HIV medicines during pregnancy and childbirth to reduce the risk of mother-to-child transmission of HIV. HIV medicines used as recommended during pregnancy can reduce the risk of mother-to-child transmission of HIV to less than 1%. For more information, read the AIDSinfo fact sheet on Preventing Mother-to-Child Transmission of HIV.

What are the types of HIV tests?

There are several HIV tests. Some are used for HIV screening and others for follow-up testing if a screening test result is HIV positive.
HIV screening tests
The HIV antibody test is the most common HIV screening test. The test checks for HIV antibodies in blood, urine, or fluids from the mouth. HIV antibodies are disease-fighting proteins that the body produces in response to HIV infection.
The time period from infection with HIV until the body produces enough HIV antibodies to be detected by an HIV antibody test is called the window period. Most people develop HIV antibodies within 3 months after they are infected with HIV. But the window period can vary depending on the HIV test used. In general, anyone who has a negative result on an HIV antibody test within 3 months of a possible exposure to HIV should have the test repeated in 3 months.
The HIV antigen/antibody test can detect both HIV antigen (a part of the virus) and HIV antibodies in blood. An antigen/antibody test can detect HIV infection before an HIV antibody test.
Follow-up HIV tests
A positive result on an HIV screening test must always be confirmed by a second HIV blood test. The following tests are used to confirm a positive result on an HIV screening test:
  • Antibody differentiation test, which distinguishes HIV-1 from HIV-2
  • HIV-1 nucleic acid test, which looks directly for HIV
  • Western blot or indirect immunofluorescence assay, which detect antibodies

How long does it take to get the results of an HIV test?

It usually takes a few days to a few weeks to get results of an HIV test. Some rapid HIV antibody tests can produce results within 30 minutes.

Is there an HIV test for home use?

There are two HIV tests approved by the U.S. Food and Drug Administration (FDA) for home use. 

The first test is a home collection kit, which involves pricking the finger for a blood sample, sending the sample to a lab for testing, and then calling the lab for results as early as the next business day. If the result is positive for HIV, the lab testing includes a follow-up test to confirm the initial HIV-positive test result. Test results include the follow-up test. 

The other approved home use test comes with a test stick and a tube with a testing solution. The test stick is used to swab the gums to get a sample of oral fluids. To get results, the test stick is inserted into the test tube. Test results are ready in 20 minutes. A positive result on this home HIV test must always be confirmed by additional HIV testing performed in a health care setting.

Is HIV testing confidential?

HIV testing can be confidential or anonymous. 

Confidential testing means that your HIV test results will include your name and other identifying information, but only people allowed to see your medical records will see your test results. HIV-positive test results may be reported to local or state health departments to be counted in statistical reports. Health departments remove all personal information (including names and addresses) from HIV test results before sharing the information with CDC. CDC uses this information for reporting purposes and does not share this information with any other organizations.

Anonymous testing means you don’t have to give your name when you take an HIV test. When you take the test, you receive a number. To get your HIV test results, you give the number instead of your name.

Where can I get tested for HIV?

Your health care provider can give you an HIV test. HIV testing is also available at many hospitals, medical clinics, community health centers, and AIDS service organizations. 

This fact sheet is based on information from the following sources:

AIDSinfo logo

HIV Overview

FDA-Approved HIV Medicines

(Last updated 4/20/2016; last reviewed 3/1/2016)
Treatment with HIV medicines is called antiretroviral therapy (ART). ART is recommended for everyone with HIV. People on ART take a combination of HIV medicines (called an HIV regimen) every day. A person's initial HIV regimen generally includes three HIV medicines from at least two different drug classes. 

ART can’t cure HIV, but HIV medicines help people with HIV live longer, healthier lives. HIV medicines also reduce the risk of HIV transmission.

The following table lists HIV medicines approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in the United States. The HIV medicines are listed according to drug class and identified by generic and brand names. Click on a drug name to view information on the drug from the AIDSinfo Drug Database. Or download the AIDSinfoDrug Database app to view the information on your Apple or Android devices.
FDA-Approved HIV Medicines
Drug Class
Generic Name 
(Other names and acronyms)
Brand Name
FDA Approval Date
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
NRTIs block reverse transcriptase, anenzyme HIV needs to make copies of itself.
abacavir 
(abacavir sulfate, ABC)
Ziagen
December 17, 1998
didanosine 
(delayed-release didanosine, dideoxyinosine, enteric-coated didanosine, ddI, ddI EC)
Videx
October 9, 1991 
Videx EC 
(enteric-coated)
October 31, 2000
emtricitabine 
(FTC)
Emtriva
July 2, 2003
lamivudine 
(3TC)
Epivir
November 17, 1995
stavudine 
(d4T)
Zerit
June 24, 1994
tenofovir disoproxil 
fumarate
 
(tenofovir DF, TDF)
Viread
October 26, 2001
zidovudine 
(azidothymidine, AZT, ZDV)
Retrovir
March 19, 1987
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
NNRTIs bind to and later alter reverse transcriptase, an enzyme HIV needs to make copies of itself.
delavirdine 
(delavirdine mesylate, DLV)
Rescriptor
April 4, 1997
efavirenz 
(EFV)
Sustiva
September 17, 1998
etravirine 
(ETR)
Intelence
January 18, 2008
nevirapine 
(extended-release nevirapine, NVP)
Viramune
June 21, 1996
Viramune XR (extended release)
March 25, 2011
rilpivirine 
(rilpivirine hydrochloride, RPV)
Edurant
May 20, 2011
Protease Inhibitors (PIs)
PIs block HIV protease, an enzyme HIV needs to make copies of itself
atazanavir 
(atazanavir sulfate, ATV)
Reyataz
June 20, 2003
darunavir 
(darunavir ethanolate, DRV)
Prezista 
June 23, 2006
fosamprenavir
(fosamprenavir calcium, FOS-APV, FPV)
Lexiva
October 20, 2003
indinavir 
(indinavir sulfate, IDV)
Crixivan
March 13, 1996
nelfinavir 
(nelfinavir mesylate, NFV)
Viracept
March 14, 1997
ritonavir 
(RTV)
Norvir
March 1, 1996
saquinavir 
(saquinavir mesylate, SQV)
Invirase
December 6, 1995
tipranavir 
(TPV)
Aptivus
June 22, 2005
Fusion Inhibitors
Fusion inhibitors block HIV from entering the CD4 cellsof the immune system.
enfuvirtide 
(T-20)
Fuzeon
March 13, 2003
Entry Inhibitors
Entry inhibitors block proteins on the CD4 cells that HIV needs to enter the cells.
maraviroc 
(MVC)
Selzentry
August 6, 2007
Integrase Inhibitors
Integrase inhibitors block HIV integrase, an enzyme HIV needs to make copies of itself.
dolutegravir 
(DTG) 
Tivicay 
August 13, 2013 
Vitekta
September 24, 2014
raltegravir 
(raltegravir potassium, RAL)
Isentress
October 12, 2007
Pharmacokinetic Enhancers
Pharmacokinetic enhancers are used in HIV treatment to increase the effectiveness of an HIV medicine included in an HIV regimen.
cobicistat 
(COBI)
Tybost
September 24, 2014
Combination HIV Medicines
Combination HIV medicines contain two or more HIV medicines from one or more drug classes.
abacavir and lamivudine 
(abacavir sulfate / lamivudine, ABC / 3TC)
Epzicom
August 2, 2004
abacavir, dolutegravir, and lamivudine
(abacavir sulfate / dolutegravir sodium / lamivudine, ABC / DTG / 3TC) 
Triumeq 
August 22, 2014
abacavir, lamivudine, and zidovudine
(abacavir sulfate / lamivudine / zidovudine, ABC / 3TC / ZDV)
Trizivir
November 14, 2000
atazanavir and cobicistat
(atazanavir sulfate / cobicistat, ATV / COBI)
Evotaz
January 29, 2015
darunavir and cobicistat
(darunavir ethanolate / cobicistat, DRV / COBI)
Prezcobix
January 29, 2015
efavirenz, emtricitabine, and tenofovir disoproxil fumarate
(efavirenz / emtricitabine / tenofovir, efavirenz / emtricitabine / tenofovir DF, EFV / FTC / TDF)
Atripla
July 12, 2006
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate
(elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide, EVG / COBI / FTC / TAF)
Genvoya
November 5, 2015
Stribild
August 27, 2012
emtricitabine, rilpivirine, and tenofovir alafenamide
(emtricitabine / rilpivirine / tenofovir AF, emtricitabine / rilpivirine / tenofovir alafenamide fumarate, emtricitabine / rilpivirine hydrochloride / tenofovir AF, emtricitabine / rilpivirine hydrochloride / tenofovir alafenamide, emtricitabine / rilpivirine hydrochloride / tenofovir alafenamide fumarate, FTC / RPV / TAF)
Odefsey
March 1, 2016
emtricitabine, rilpivirine, and tenofovir disoproxil fumarate
(emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate, emtricitabine / rilpivirine / tenofovir, FTC / RPV / TDF)
Complera
August 10, 2011
emtricitabine and tenofovir alafenamide
(emtricitabine / tenofovir AF, emtricitabine / tenofovir alafenamide fumarate, FTC / TAF)
Descovy 
April 4, 2016
emtricitabine and tenofovir disoproxil fumarate
(emtricitabine / tenofovir, FTC / TDF)
Truvada
August 2, 2004
Combivir
September 27, 1997
lopinavir and ritonavir
(ritonavir-boosted lopinavir, LPV/r, LPV / RTV)
Kaletra
September 15, 2000

This fact sheet is based on information from the following sources:

AIDSinfo logo

HIV Overview

HIV/AIDS Clinical Trials

(Last updated 9/15/2015; last reviewed 9/15/2015)

Key Points

·  HIV/AIDS clinical trials are research studies done to look at new ways to prevent, detect, or treat HIV/AIDS. Clinical trials are the fastest way to determine if new medical approaches to HIV/AIDS are safe and effective in people.
·  Examples of HIV/AIDS clinical trials under way include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV.
·  The benefits and possible risks of participating in an HIV/AIDS clinical trial are explained to study volunteers before they decide whether to participate in a study.
·  Use the AIDSinfo clinical trial search to find HIV/AIDS studies looking for volunteer participants. Some HIV/AIDS clinical trials enroll only people infected with HIV. Other studies enroll people who aren’t infected with HIV.

What is a clinical trial?

A clinical trial is a research study done to evaluate new medical approaches in people. New approaches can include:
  • new medicines or new combinations of medicines
  • new surgical procedures or devices
  • new ways to use an existing medicine or device
Clinical trials are the fastest way to determine whether new medical approaches are safe and effective in people.

What is an HIV/AIDS clinical trial?

HIV/AIDS clinical trials help researchers find better ways to prevent, detect, or treat HIV/AIDS. All the medicines used to treat HIV/AIDS in the United States were first studied in clinical trials. 

Examples of HIV/AIDS clinical trials under way include:
  • studies of new medicines to treat HIV
  • studies of vaccines to prevent or treat HIV
  • studies of medicines to treat infections related to HIV

Can anyone participate in an HIV/AIDS clinical trial?

It depends on the study. Some HIV/AIDS clinical trials enroll only people infected with HIV. Other studies include people who aren’t infected with HIV.

Other factors such as age, gender, HIV treatment history, or other medical conditions may also restrict who can participate in an HIV/AIDS clinical trial.

What are the benefits of participating in an HIV/AIDS clinical trial?

Participating in an HIV/AIDS clinical trial can provide benefits. For example, many people participate in HIV/AIDS clinical trials because they want to contribute to HIV/AIDS research. They may have HIV or know somebody who is infected with HIV.

People with HIV who participate in an HIV/AIDS clinical trial may benefit from new HIV medicines before they are widely available. They can also receive regular and careful medical care from a research team that includes doctors and other health professionals. Often the medicines and medical care are free of charge.

Sometimes people get paid for participating in a clinical trial. For example, they may receive money or a gift card. They may be reimbursed for the cost of meals or transportation.

Are HIV/AIDS clinical trials safe?

Researchers try to make HIV/AIDS clinical trials as safe as possible. However, volunteering to participate in a study that is testing an experimental treatment for HIV can involve risks of varying degrees. Risks can include unpleasant, serious, or even life-threatening side effects from the treatment being studied. 

In a process called informed consent, study volunteers are informed of the possible risks and benefits of a clinical trial. Understanding the risks and benefits helps volunteers decide whether to participate in the study.

If I decide to participate in a clinical trial, will my personal information be shared?

The privacy of study volunteers is important to everyone involved in an HIV/AIDS clinical trial. The informed consent process includes an explanation of how a study volunteer’s personal information is protected.

How can I find an HIV/AIDS trial in which to participate?

To find an HIV/AIDS clinical trial looking for volunteers, use the AIDSinfo clinical trial search. For help with your search, call an AIDSinfo health information specialist at 1-800-448-0440 or e-mail contactus@aidsinfo.nih.gov.

This fact sheet is based on information from the following sources:

AIDSinfo logo

HIV Overview

What is an Investigational HIV Drug?

(Last updated 4/1/2016; last reviewed 4/1/2016)

Key Points

·  An investigational HIV drug is a drug that is being tested and is not approved by the U.S. Food and Drug Administration (FDA) for general use or sale in the United States.
·  Investigational HIV drugs include drugs to treat or prevent HIV and vaccines to treat or prevent HIV.
·  In most cases, an investigational drug must be proven effective and show continued safety in a Phase III clinical trial to be considered for FDA approval.
·  Access to investigational HIV drugs can be made through clinical trials and expanded access programs.

What is an investigational HIV drug?

An investigational HIV drug is a drug that is being tested to treat or prevent HIV infection and is not approved by the U.S. Food and Drug Administration (FDA) for general use or sale in the United States. Medical research studies—also called clinical trials—are conducted to evaluate the safety and effectiveness of an investigational HIV drug. 

What types of investigational HIV drugs are being studied?

Currently, there are investigational drugs for treating HIV and preventing HIV. There are also investigational drugs for treating HIV-related opportunistic infections. (Examples of opportunistic infections include pneumonia and tuberculosis.) 
Although no HIV vaccines exist yet, researchers are studying investigational preventive vaccines and treatment vaccines. A preventive HIV vaccine is a vaccine to prevent HIV infection in people who do not have HIV. An HIV treatment vaccine, also called a therapeutic vaccine, is a vaccine to slow the progression of HIV infection or delay the onset of AIDS.

How are clinical trials of investigational drugs conducted?

Clinical trials, which are medical research studies, are conducted in phases. Each phase has a different purpose and helps researchers answer different questions about the investigational drug.
  • Phase I trials: Researchers test the investigational drug in a small group of people (20–80) for the first time. The purpose is to evaluate its safety and identify side effects.
  • Phase II trials: The investigational drug is administered to a larger group of people (100–300) to determine its effectiveness and to further evaluate its safety.
  • Phase III trials: The investigational drug is administered to large groups of people (1,000–3,000) to confirm its effectiveness, monitor side effects, compare it with standard or equivalent treatments, and collect information that will allow the investigational drug to be used safely.
In most cases, an investigational drug must be proven effective and must show continued safety in a Phase III clinical trial to be considered for approval by FDA for sale in the United States. (Some drugs go through FDA’s accelerated approval process and are approved before a Phase III clinical trial is complete.) After a drug is approved by FDA and made available to the public, researchers track its safety in Phase IV trials to seek more information about the drug’s risks, benefits, and optimal use.
https://aidsinfo.nih.gov/images/factsheet/InvestigationalHIVDrug_700pix.jpg

How can I get access to an investigational HIV drug?

One way to get access to an investigational HIV drug is by enrolling in a clinical trial that is studying the drug. Another way is through an expanded access program. Expanded access involves using an investigational drug outside of a clinical trial to treat a person who has a serious or immediately life-threatening disease and who has no FDA-approved treatment options. Drug companies must have permission from FDA to make an investigational drug available for expanded access. Talk to your health care provider to see if you may qualify to take part in an expanded access program.

How can I find a clinical trial on an investigational HIV drug?

To find an HIV/AIDS clinical trial on an investigational HIV drug, use the AIDSinfo clinical trial search. For help with your search, call an AIDSinfo health information specialist at 1-800-448-0440 or email ContactUs@aidsinfo.nih.gov. 

You can also search the National Institutes of Health’s (NIH’s) online database of clinical trials that are taking place at NIH’s Clinical Center, which is located in Bethesda, MD. And you can join ResearchMatch, which is a free, secure registry that makes it easier for the public to become involved in clinical trials. 

Is it safe to use an investigational HIV drug?

One goal of HIV research is to identify new drugs that are less toxic and have fewer side effects. Researchers also try to make HIV/AIDS clinical trials as safe as possible. But investigational HIV drugs may have side effects that are not well known yet. Although this risk of poorly understood side effects is explained to you before you start taking the investigational drug, this makes it hard to know your actual risk. As testing of an investigational HIV drug continues, additional information on possible side effects is collected.

How can I find more information on investigational HIV drugs?

To find more information on investigational HIV drugs, use the AIDSinfo Drug Database, which includes up-to-date information on many investigational HIV drugs.

This fact sheet is based on information from the following sources: